TY - JOUR
T1 - PET and PET/CT in Management of the Lymphomas
AU - Podoloff, Donald A.
AU - Macapinlac, Homer A.
PY - 2007/7
Y1 - 2007/7
N2 - Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.
AB - Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicine and radiology imaging modality in the management of lymphoma. FDG-PET detects more disease sites and involved organs than conventional staging procedures, including CT, and has a large influence on staging. FDG-PET performed during and after therapy seems to provide considerable prognostic information. The impact on patient outcome is not clear, however, because no controlled trials have yet been conducted and follow-up periods are generally short.
UR - http://www.scopus.com/inward/record.url?scp=34547731496&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547731496&partnerID=8YFLogxK
U2 - 10.1016/j.rcl.2007.05.008
DO - 10.1016/j.rcl.2007.05.008
M3 - Review article
C2 - 17706533
AN - SCOPUS:34547731496
SN - 0033-8389
VL - 45
SP - 689
EP - 696
JO - Radiologic Clinics of North America
JF - Radiologic Clinics of North America
IS - 4
ER -